This cluster groups 2 independently calculated changes: Cash & equivalents decreased 59.7%; Operating cash flow decreased 36.1%.
2 evidence-backed components· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTAutonomix Medical, Inc.'s latest supported as-filed period reports revenue of $0. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents decreased 59.7%; Operating cash flow decreased 36.1%.
2 evidence-backed componentsShares outstanding changed -81.1% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
AMIX · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001437749-26-029835SEC ↗4Sep 8, 2026Period Sep 3, 20260001437749-26-029833SEC ↗4Sep 8, 2026Period Sep 3, 20260001437749-26-029830SEC ↗8-KAug 26, 2026Period Aug 24, 20260001437749-26-029024SEC ↗10-QAug 13, 2026Period Jun 30, 20260001437749-26-027429SEC ↗8-KJul 28, 2026Period Jul 28, 20260001437749-26-024597SEC ↗8-KJul 15, 2026Period Jul 13, 20260001437749-26-023638SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 3, 2026Filed Sep 8, 2026 | KLEMP WALTER VDirector | Grant Or AwardDirect | 13,000 | — | — | Form 4 ↗ |
| Sep 3, 2026Filed Sep 8, 2026 | Bisson LoriDirector | Grant Or AwardDirect | 13,000 | — | — | Form 4 ↗ |
| Sep 3, 2026Filed Sep 8, 2026 | Hauser BradleyCEO and President | Grant Or AwardDirect | 27,000 | — | — | Form 4 ↗ |
| Aug 11, 2025Filed Aug 13, 2025 | Bisson LoriDirector | Disposition To IssuerDirect | 18,862 | — | — | Form 4 ↗ |
| Aug 11, 2025Filed Aug 13, 2025 | Bisson LoriDirector |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating cash flow changed -36.1% from the comparable as-filed period.
Cash & equivalents changed -59.7% from the comparable as-filed period.
Working capital changed -55.1% from the comparable as-filed period.
Operating income changed +19.0% from the comparable as-filed period.
Current assets changed -55.8% from the comparable as-filed period.
Current liabilities changed -58.4% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001437749-26-023248| Disposition To IssuerDirect |
| 46,680 |
| — |
| — |
| Form 4 ↗ |
| Aug 11, 2025Filed Aug 13, 2025 | Smith Trent N.CFO | Disposition To IssuerDirect | 11,405 | — | — | Form 4 ↗ |
| Aug 11, 2025Filed Aug 13, 2025 | Smith Trent N.CFO | Disposition To IssuerDirect | 21,250 | — | — | Form 4 ↗ |
| Aug 11, 2025Filed Aug 13, 2025 | Hauser BradleyCEO and President | Disposition To IssuerDirect | 45,000 | — | — | Form 4 ↗ |
| Aug 11, 2025Filed Aug 13, 2025 | Capelli ChristopherDirector | Disposition To IssuerDirect | 3,750 | — | — | Form 4 ↗ |
| Aug 11, 2025Filed Aug 13, 2025 | KLEMP WALTER VDirector | Disposition To IssuerDirect | 8,773 | — | — | Form 4 ↗ |
| Jun 21, 2024Filed Jun 24, 2024 | Smith Trent N.CFO | Grant Or AwardDirect | 228,087 | — | — | Form 4 ↗ |
| Jun 21, 2024Filed Jun 24, 2024 | KLEMP WALTER VDirector | Grant Or AwardDirect | 175,452 | — | — | Form 4 ↗ |
| Jun 21, 2024Filed Jun 24, 2024 | Bisson LoriDirector | Grant Or AwardDirect | 377,221 | — | — | Form 4 ↗ |
| Jun 18, 2024Filed Jul 26, 2024 | Robins David AndrewDirector | Open Market PurchaseIndirect | 103,990 | $0 | $104 | Form 4 ↗ |
| Jun 18, 2024Filed Jun 20, 2024 | BioStar Ventures III, L.P.Reporting owner | Open Market PurchaseDirect | 1,088,000 | $0 | $30,464 | Form 4 ↗ |
| Jun 17, 2024Filed Jun 20, 2024 | Hauser BradleyCEO and President | Grant Or AwardDirect | 900,000 | — | — | Form 4 ↗ |